Helsinki-based Avenue Biosciences raises €2.3 million to scale AI-enhanced protein engineering

Avenue Biosciences, a transatlantic biotechnology company specialising in novel protein engineering technologies, announced the successful closing of their ... Read more

Bron:

EU-startups.com